Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.

Tropical medicine & international health : TM & IH·2020

Same author

Indo-Oceanic <i>Mycobacterium tuberculosis</i> strains from Thailand associated with higher mortality.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019

Same author

Use of network analysis multidrug-resistant tuberculosis contact investigation in Kanchanaburi, Thailand.

Tropical medicine & international health : TM & IH·2018

Same author

Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.

Acta neurologica Scandinavica·2017

Same author

Strain-based HLA association analysis identified HLA-DRB1*09:01 associated with modern strain tuberculosis.

HLA·2017

Same author

Impact of HIV on inpatient mortality and complications in stroke in Thailand: a National Database Study.

Epidemiology and infection·2017

Search research articles

Related Experiment Video

Updated: May 30, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Association between apolipoprotein E genotypes and Parkinson's disease.

T Pulkes¹, C Papsing, S Mahasirimongkol

¹Division of Neurology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama 6 Road, Bangkok 10400, Thailand. ratpk@mahidol.ac.th

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

|July 26, 2011

Summary

The first Thai study found a higher frequency of the apolipoprotein E (APOE)-ε2 allele in Parkinson

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Related Experiment Videos

Last Updated: May 30, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Area of Science:

Neuroscience
Genetics
Epidemiology

Background:

Conflicting evidence exists regarding the association between apolipoprotein E (APOE) alleles and Parkinson's disease (PD).
Recent research suggests APOE's role in α-synuclein-mediated neurodegeneration, a key pathway in PD.
The genetic link between APOE and PD requires further investigation in diverse populations.

Purpose of the Study:

To investigate the association between APOE genotypes and sporadic Parkinson's disease (PD) in the Thai population.
To determine if specific APOE alleles are risk factors for PD in this ethnic group.
To contribute to clarifying the role of APOE in PD pathogenesis.

Main Methods:

A case-control study was conducted.
Genotyping of apolipoprotein E (APOE) alleles was performed.
Frequencies of APOE genotypes were analyzed in 155 PD patients and 158 controls.

Main Results:

A significantly higher frequency of the APOE-ε2 allele was observed in Parkinson's disease (PD) patients compared to controls.
The odds ratio for PD associated with the APOE-ε2 allele was 2.309 (95% CI: 1.111-4.799).
This finding suggests a potential susceptibility role for APOE-ε2 in PD within the studied Thai population.

Conclusions:

The APOE-ε2 allele may be associated with an increased risk of developing Parkinson's disease (PD) in the Thai population.
Genetic association studies require careful interpretation due to potential confounding factors.
Further research in large, homogeneous populations is needed to confirm the role of APOE genotypes in PD susceptibility.